Efficacy in iNPH Shunting (PENS) Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Luciano, MD, PhD
Johns Hopkins University
Principal Investigator - Richard Holubkov, PhD
University of Utah
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- University of British Columbia
Vancouver, Canada
- Umeå University
Umeå, Sweden
- University of California, Davis
Davis, California, United States
- University of Southern California
Los Angeles, California, United States
- Pacific Neuroscience Institute
Santa Monica, California, United States
- University of South Florida
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Indiana University
Indianapolis, Indiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Mount Sinai Health System
New York, New York, United States
- New York University Langone Health
New York, New York, United States
- Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
- Oregon Health & Science University
Portland, Oregon, United States
- the University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 May 2022
- Primary completion
- 31 May 2027
- Completion
- 31 Aug 2027
- Last update posted
- 8 May 2026
- Registered enrollment
- 100
- Registry id
- NCT05081128
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.